Brian D. Doerner, a Philadelphia-based business and finance partner noted for his skill with mergers and acquisitions, licensing transactions, and securities issues, has been named co-practice leader of Ballard Spahr’s Life Sciences and Technology Group, firm Chair Mark Stewart announced today.

Mr. Doerner recently returned to full-time practice at the firm after serving as interim general counsel for an NYSE-listed multinational client.

“The experience as general counsel gave me great insight into the issues our clients face and will be a real plus as I help to lead one of the most vibrant practices in the firm,” Mr. Doerner said.

Mr. Doerner has handled numerous strategic alliance transactions, private equity transactions, initial public offerings, and private placements for clients in the life sciences and technology industries.

Mr. Doerner, who will work alongside co-practice leader Douglas M. Fox, assumes leadership of a department that is deep and growing. In February, the firm welcomed as a partner Katayun I. Jaffari, who led the securities practice at Saul Ewing. Ms. Jaffari's securities work focuses on the biotechnology, energy, and technology sectors. Joining the practice last week was Joseph W. La Barge, the former Vice President, General Counsel, and Chief Compliance Officer at Tengion, Inc. Mr. La Barge advises life sciences and technology industry clients on mergers and acquisitions, capital raising, and agreements related to research, licensing, and collaboration.